Eran Diamant
Papers
2
Total Citations
29
H-Index
2
About
Eran Diamant is a leading researcher in the field of botulinum neurotoxin (BoNT) countermeasures, with a focused expertise in developing advanced antibody-based therapeutics and detection tools. His major contributions center on engineering and evaluating oligoclonal and monoclonal antibody preparations that can neutralize the most lethal BoNT serotypes—A, B, and E—responsible for the vast majority of human botulism cases. In his highly cited 2014 study (27 citations), Diamant demonstrated the synergistic neutralizing effect of oligoclonal antibody cocktails, highlighting their superiority over traditional polyclonal antibodies for both treatment and detection. His earlier 2013 work pioneered a trivalent immunization protocol combined with a simultaneous differential robotic screen to generate serotype-specific monoclonal antibodies, a methodological breakthrough that streamlined the development of targeted antitoxins. Diamant’s research has profound implications for biodefense and public health, offering scalable, reproducible alternatives to animal-derived polyclonal antibodies. His innovative approaches not only enhance the efficacy of botulism treatments but also set new standards for rapid antibody discovery against emerging biological threats, making him a pivotal figure in toxinology and immunotherapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2